✦ LIBER ✦

Decrease in the response to ADH of the rat kidney as a result of early postnatal treatment with cortisol

✍ Scribed by L. N. Ivanova; E. I. Solyenov; M. N. Zelenina; I. I. Khegay

Publisher: Springer
Year: 1987
Tongue: English
Weight: 529 KB
Volume: 408
Category: Article
ISSN: 0031-6768
DOI: 10.1007/bf00581124

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A decrease of cytosol estrogen receptors

A decrease of cytosol estrogen receptors in the hypothalamus as a result of treatment of neonatal rats with glutamate

✍ J. F. Rodriguez-Sierra; J. D. Blaustein; C. A. Blake; R. W. Clough; K. A. Elias 📂 Article 📅 1982 🏛 Springer-Verlag 🌐 English ⚖ 961 KB

Pre-treatment energy status of primary r

Pre-treatment energy status of primary rat tumours as the best predictor of response to 5-fluorouracil chemotherapy: a magnetic resonance spectroscopy study in vivo

✍ Laurent P. Lemaire; Paul M. J. McSheehy; John R. Griffiths 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 346 KB

The influence of genetic variation in th

The influence of genetic variation in the HLA–DRB1 and LTA–TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept

✍ Lindsey A. Criswell; Raymond F. Lum; Kevin N. Turner; Blanche Woehl; Yuanqing Zh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 3 views

## Abstract ## Objective To examine the roles of specific genetic polymorphisms as predictors of response to treatment of early rheumatoid arthritis (RA). ## Methods Subjects included 457 patients with early RA (duration of ≤3 years) who participated in a randomized controlled trial comparing we

Treatment of Bendamustine and Prednisone

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

✍ W. Pönisch; P. S. Mitrou; K. Merkle; M. Herold; M. Assmann; G. Wilhelm; K. Dachs 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 344 KB

Lymphoblastoid interferon alfa-n1 improv

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l

Tocilizumab inhibits structural joint da

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year

✍ Joel M. Kremer; Ricardo Blanco; Marek Brzosko; Ruben Burgos-Vargas; Anne-Marie H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 3 views